Germany
Japan
United Kingdom
China
Antibodies
Download
Rabbit Polyclonal CD4 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat, Rabbit |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to an C-terminal region of the human CD4 protein (within residues 400-458). [Swiss-Prot P01730] |
Rabbit Polyclonal CX3CR1 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | CX3CR1 antibody was raised against a 20 amino acid peptide near the amino terminus of human CX3CR1. The immunogen is located within the first 50 amino acids of CX3CR1. |
GRIA3 Rabbit Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human GRIA3 |
5 HT 2A (HTR2A) rabbit polyclonal antibody
| Applications | IF, IHC, WB |
| Reactivities | Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit polyclonal anti-CELSR1 antibody
| Applications | IF |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human CELSR1. |
Rabbit Polyclonal MFSD2A Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | MFSD2A antibody was raised against an 18 amino acid synthetic peptide near the carboxy terminus of human MFSD2A. The immunogen is located within the last 50 amino acids of MFSD2A. |
Rabbit Polyclonal Calnexin Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat, Hamster |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to a C-terminal portion of the rat Calnexin protein (between residues 550-591) [UniProt P35565] |
Rabbit Polyclonal DRAM Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | DRAM antibody was raised against a 16 amino acid synthetic peptide from near the amino terminus of human DRAM. The immunogen is located within amino acids 30 - 80 of DRAM. |
Rabbit Polyclonal ORAI1 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | ORAI1 antibody was raised against a 16 amino acid synthetic peptide from near the carboxy terminus of human ORAI1. The immunogen is located within the last 50 amino acids of ORAI1. |
Mouse monoclonal anti-ATP1A1(NaK ATPase) antibody, clone 464.6, Loading control
| Applications | FC, IHC, WB |
| Reactivities | Canine, Human, Mouse, Porcine, Primate, Rabbit, Rat, Sheep, Xenopus |
| Conjugation | Unconjugated |
Rabbit polyclonal anti-MTR1A antibody
| Applications | IF |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human MTR1A. |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Rat
Applications
- IF
Families
- Transmembrane
Filter by
Target Symbol
- L1CAM (81)
- ERBB2 (78)
- APP (61)
- PTPRE (60)
- NPR3 (56)
- RNF144B (50)
- SPG7 (50)
- SYP (50)
- POR (40)
- KCNJ3 (35)
- RPN1 (35)
- LGR5 (32)
- NPTN (30)
- SYT4 (28)
- BEST3 (25)
- PDGFRB (25)
- SIL1 (25)
- FGFR2 (23)
- SLC7A8 (23)
- PDIA4 (21)
- ILVBL (20)
- SSR1 (20)
- EGFR (17)
- RET (17)
- B3GNT2 (15)
- CISD1 (15)
- CLDN6 (15)
- CYB5R1 (15)
- CYP2A6 (15)
- GDAP1L1 (15)
- LMAN1 (15)
- PCDH7 (15)
- PTPN1 (15)
- ROMO1 (15)
- SCAMP2 (15)
- CD36 (11)
- SHH (11)
- BSG (10)
- HMOX2 (10)
- NTRK3 (10)
- PMEL (10)
- PTCH1 (10)
- CANX (9)
- FOLH1 (8)
- PDCD1 (7)
- BCL2L1 (6)
- GJA1 (6)
- JPH2 (6)
- LPAR1 (6)
- NTRK2 (6)
- REEP2 (6)
- STX1A (6)
- AQP1 (5)
- BTN1A1 (5)
- CD22 (5)
- CD80 (5)
- CDH2 (5)
- CLDN5 (5)
- DPP4 (5)
- ENG (5)
- ENPEP (5)
- FATE1 (5)
- KLK8 (5)
- LEMD3 (5)
- LGR6 (5)
- MET (5)
- PCSK7 (5)
- PRTG (5)
- SCARB1 (5)
- SLC18A2 (5)
- SLC30A3 (5)
- SPINT1 (5)
- TAPBPL (5)
- TFR2 (5)
- TMED1 (5)
- TMEM100 (5)
- TMEM230 (5)
- BAX (4)
- FGFR3 (4)
- ERN1 (3)
- ORAI1 (3)
- SCARB2 (3)
- SDCBP (3)
- TOMM70 (3)
- ADORA3 (2)
- ADRA1B (2)
- AGTR1 (2)
- ANTXR1 (2)
- AQP2 (2)
- ATP7B (2)
- BCL2L13 (2)
- CADM3 (2)
- CASR (2)
- CD248 (2)
- CD63 (2)
- CERS5 (2)
- CNGA2 (2)
- CX3CR1 (2)
- DRAM1 (2)
- EDNRA (2)
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (217)
- Calcium signaling pathway (156)
- Prostate cancer (147)
- Cell adhesion molecules (CAMs) (138)
- Focal adhesion (134)
- Adherens junction (120)
- Pancreatic cancer (103)
- Bladder cancer (99)
- ErbB signaling pathway (97)
- Endometrial cancer (95)
- Non-small cell lung cancer (95)
- Axon guidance (92)
- Neuroactive ligand-receptor interaction (85)
- MAPK signaling pathway (83)
- Metabolic pathways (81)
- Alzheimer's disease (79)
- Cytokine-cytokine receptor interaction (78)
- Regulation of actin cytoskeleton (77)
- Endocytosis (76)
- Colorectal cancer (63)
- Gap junction (62)
- Melanoma (50)
- Glioma (45)
- N-Glycan biosynthesis (36)
- Leukocyte transendothelial migration (30)
- Basal cell carcinoma (29)
- Vibrio cholerae infection (26)
- Hematopoietic cell lineage (25)
- Neurotrophin signaling pathway (25)
- Hedgehog signaling pathway (24)
- Epithelial cell signaling in Helicobacter pylori infection (23)
- Tight junction (22)
- GnRH signaling pathway (21)
- Adipocytokine signaling pathway (17)
- Apoptosis (17)
- Dorso-ventral axis formation (17)
- Thyroid cancer (17)
- Amyotrophic lateral sclerosis (ALS) (16)
- Drug metabolism - cytochrome P450 (16)
- Glycosphingolipid biosynthesis - lacto and neolacto series (16)
- Retinol metabolism (16)
- Amino sugar and nucleotide sugar metabolism (15)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (15)
- Caffeine metabolism (15)
- Drug metabolism - other enzymes (15)
- ECM-receptor interaction (15)
- Insulin signaling pathway (15)
- Keratan sulfate biosynthesis (15)
- Melanogenesis (13)
- PPAR signaling pathway (12)
- Porphyrin and chlorophyll metabolism (12)
- Parkinson's disease (11)
- Vascular smooth muscle contraction (11)
- Antigen processing and presentation (10)
- Huntington's disease (10)
- Jak-STAT signaling pathway (10)
- T cell receptor signaling pathway (10)
- Dilated cardiomyopathy (9)
- Lysosome (9)
- Renin-angiotensin system (9)
- Toll-like receptor signaling pathway (9)
- Wnt signaling pathway (9)
- Chemokine signaling pathway (8)
- Chronic myeloid leukemia (8)
- Natural killer cell mediated cytotoxicity (8)
- Notch signaling pathway (8)
- p53 signaling pathway (8)
- Allograft rejection (7)
- B cell receptor signaling pathway (7)
- Cardiac muscle contraction (7)
- Graft-versus-host disease (7)
- SNARE interactions in vesicular transport (7)
- Small cell lung cancer (7)
- Systemic lupus erythematosus (7)
- Type I diabetes mellitus (7)
- Viral myocarditis (7)
- Hypertrophic cardiomyopathy (HCM) (6)
- Renal cell carcinoma (6)
- TGF-beta signaling pathway (6)
- Autoimmune thyroid disease (5)
- Long-term depression (5)
- Oocyte meiosis (5)
- Oxidative phosphorylation (5)
- Progesterone-mediated oocyte maturation (5)
- Prion diseases (4)
- Purine metabolism (4)
- RIG-I-like receptor signaling pathway (4)
- Cytosolic DNA-sensing pathway (3)
- Heparan sulfate biosynthesis (3)
- Long-term potentiation (3)
- O-Glycan biosynthesis (3)
- Type II diabetes mellitus (3)
- ABC transporters (2)
- Asthma (2)
- Fc epsilon RI signaling pathway (2)
- NOD-like receptor signaling pathway (2)
- Taste transduction (2)
- Arachidonic acid metabolism (1)
- Biosynthesis of unsaturated fatty acids (1)
- Chondroitin sulfate biosynthesis (1)
- Fatty acid metabolism (1)
- Glutathione metabolism (1)
- Linoleic acid metabolism (1)
- Metabolism of xenobiotics by cytochrome P450 (1)
- Olfactory transduction (1)
- Pathogenic Escherichia coli infection (1)
- Primary immunodeficiency (1)
- Pyrimidine metabolism (1)